首站-论文投稿智能助手
典型文献
Sanofi-Cell Research outstanding paper award of 2021
文献摘要:
We are pleased to announce the winners of the 2021 Sanofi-Cell Research Outstanding Research Article Award:Dr Qiangfeng Cliff Zhang,for his paper entitled"Predicting dynamic cellular protein-RNA interactions by deep learning using in vivo RNA structures";1 Drs Boxun Lu and Yu Ding,for their paper entitled"Degradation of lipid droplets by chimeric autophagy-tethering compounds";2 and Drs Chen-Yu Zhang,Qipeng Zhang and Fangyu Wang for their paper entitled"SIDT1-dependent absorption in the stomach mediates host uptake of dietary and orally administered microRNAs".3 Each award consists of a prize of ¥40,000 sponsored by Sanofi.
文献关键词:
作者姓名:
Cell Research Editorial Team
作者机构:
Shanghai Institute of Biochemistry and Cell Biology,Center for Excellence in Molecular Cell Science,Chinese Academy of Sciences,Shanghai,China
引用格式:
[1]Cell Research Editorial Team-.Sanofi-Cell Research outstanding paper award of 2021)[J].细胞研究(英文版),2022(12):1035
A类:
Sanofi,Qiangfeng,Cliff,Drs,Boxun,Qipeng,Fangyu,SIDT1
B类:
Cell,Research,outstanding,paper,award,We,are,pleased,announce,winners,Outstanding,Article,Award,Zhang,his,entitled,Predicting,dynamic,cellular,protein,interactions,by,deep,learning,using,vivo,structures,Lu,Yu,Ding,their,Degradation,lipid,droplets,chimeric,autophagy,tethering,compounds,Chen,Wang,dependent,absorption,stomach,mediates,host,uptake,dietary,orally,administered,microRNAs,Each,consists,prize,sponsored
AB值:
0.568143
相似文献
Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer 's disease: a meta-analysis and systematic review
Wei-Lin Liu;Hua-Wei Lin;Miao-Ran Lin;Yan Yu;Huan-Huan Liu;Ya-Ling Dai;Le-Wen Chen;Wei-Wei Jia;Xiao-Jun He;Xiao-Ling Li;Jing-Fang Zhu;Xie-Hua Xue;Jing Tao;Li-Dian Chen-Academy of Rehabilitation Industry,Fujian University of Traditional Chinese Medicine,Fuzhou,Fujian Province,China;Department of Biochemistry and Molecular Biology,University of Oklahoma Health Sciences Center,Oklahoma City,OK,USA;National-Local Joint Engineering Research Center of Rehabilitation Medicine Technology,Fujian University of Traditional Chinese Medicine,Fuzhou,Fujian Province,China;Affiliated Rehabilitation Hospital of Fujian University of Traditional Chinese Medicine,Fuzhou,Fujian Province,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。